web analytics
27.3 C
Karachi
Thursday, August 14, 2025
- Advertisement -

Patients on weight-loss drugs should inform doctor before surgery

TOP NEWS

Reuters
Reuters
Reuters is an international news organisation owned by Thomson Reuters

The European Medicines Agency (EMA) said on Friday patients taking weight-loss drugs such as Novo Nordisk’s Wegovy should inform their doctor ahead of surgery, due to the risk of respiratory complications potentially associated with such drugs.

Weight-loss drugs, including Wegovy and Eli Lilly’s Zepbound and Mounjaro, belong to a class known as GLP-1 receptor agonists that slow the process of emptying food contents from the stomach, making users feel full for longer.

So a patient taking such drugs could end up with a stomach full of food on an operating table, despite fasting the night before surgery, which could lead to a rare complication of stomach contents moving into the respiratory tract, potentially causing pneumonia.

However, the regulator said it had not yet found a causal link between the GLP-1 drugs and the complication, called aspiration.

The EMA’s drug safety committee said the product information of weight-loss drugs will be updated to include a warning to patients that they should inform their doctor if they are scheduled to undergo surgery under anesthesia or deep sedation.

- Advertisement -
- Advertisement -
 

Trending

POLL

After Pakistan's crushing response. Will India ever resort to cowardly attacks like Operation Sindoor again?

- Advertisement -
 

MORE STORIES